Viewing Study NCT04985357


Ignite Creation Date: 2025-12-24 @ 7:03 PM
Ignite Modification Date: 2026-02-21 @ 8:27 AM
Study NCT ID: NCT04985357
Status: WITHDRAWN
Last Update Posted: 2024-11-25
First Post: 2021-07-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Sponsor: Travera Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage III Breast Cancer View
None Stage IV Breast Cancer View
None Stage III Lung Cancer View
None Stage IV Lung Cancer View
None AML View
None Multiple Myeloma in Relapse View
None Carcinoma View
None Carcinoma, Pancreatic View
None Carcinoma of Lung View
None Carcinoma, Non-Small-Cell Lung View
None Carcinoma Breast View
None Carcinoma Prostate View
None Carcinoma, Hepatocellular View
None Carcinoma, Renal Cell View
None Carcinoma, Neuroendocrine View
None Carcinoma, Small Cell Lung View
None Carcinoma, Ovarian View
None Carcinoma Bladder View
None Carcinoma of Esophagus View
None Carcinoma Cervix View
None Carcinoma, Thymic View
None Carcinoma, Ductal View
None Carcinoma of the Head and Neck View
None Carcinoma of the Lip View
None Carcinoma of the Oral Cavity View
None Carcinoma of Unknown Primary View
None Carcinoma of the Skin View
None Carcinoma of the Anus View
None Carcinoma of the Larynx View
None Carcinoma of the Penis View
None Carcinoma of the Oropharynx View
None Carcinoma of the Appendix View
None Carcinoma of the Paranasal Sinus View
None Carcinoma of the Vulva View
None Malignant Pleural Effusion View
None Malignant Ascites View
None Mesothelioma View
None Cholangiocarcinoma View
Keywords: